Cannabis Corner: Vivo offers you growth at a penny price

Article Excerpt

In this issue we look at a junior cannabis stock whose conservative approach to growth over the last few years hasn’t kept it from falling along with most cannabis companies. Still, that strategy should let it withstand the current shakeout and position its investors for a substantial rebound. Vivo Cannabis has limited itself to two main growing sites, and, unlike so many of today’s troubled rivals, stayed away from costly and ill-timed domestic and foreign acquisitions in the race to boost market share. Instead, the company stayed focused on producing the highest-quality cannabis for customers, as well as developing products for Canada’s recent legalization of Cannabis 2.0 products. They include vapes, edibles, topicals and premium concentrates. What’s more, Vivo is set to receive European quality certification for its Canadian operations and it expects to begin shipping products to Germany and other countries soon after. Vivo Cannabis is a buy for aggressive investors. VIVO CANNABIS $0.38 (Toronto symbol VIVO; TSINetwork Rating: Speculative) (vivocannabis.com; Shares o/s: 295.9 million; Market…